STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Movano Health Launches EvieAI Virtual Wellness Assistant

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Movano Health (MOVE) has announced the beta release of EvieAI, a virtual wellness assistant integrated into their Evie smart ring's companion app. This feature marks the first medical journal-trained AI companion in a wearable device, trained on over 100,000 medical journals.

The AI assistant will provide personalized health insights based on users' metrics collected by Evie's sensors, including heart rate, blood oxygen, menstrual cycle information, skin temperature, sleep, exercise, and mood. Unlike general AI assistants, EvieAI focuses on medical accuracy and implements industry-standard encryption for data protection.

The Evie Ring, priced at $269 with no subscription fees, features 4+ days of battery life, 60-minute recharge time, and is available in gold, rose gold, and silver finishes. The beta version of EvieAI is currently available for iOS users at no additional cost to existing customers.

Loading...
Loading translation...

Positive

  • Launch of EvieAI feature adds value to existing product without additional cost
  • Unique market position as first medical journal-trained AI in wearables
  • No subscription fees required for the base product or AI feature

Negative

  • EvieAI beta to iOS users only, excluding Android market
  • Future integration with personal health metrics not yet implemented

Insights

The launch of EvieAI represents a strategic differentiation in the competitive wearables market. Training the AI exclusively on medical journal data creates a significant barrier to entry and positions Evie Ring as a more credible health solution compared to general-purpose wearables. The technology stack combining encrypted health data with AI capabilities suggests strong potential for developing a proprietary health insights platform.

However, the market impact may be by several factors: iOS-only availability restricts the addressable market, the beta release indicates early development stage and the lack of immediate integration with ring sensor data means the AI cannot yet deliver fully personalized insights. The $269 price point without subscription fees, while competitive, may challenge profitability given the AI infrastructure costs.

While innovative, this product enhancement enters a saturated wearables market where major players like Apple, Fitbit and Oura already dominate. The female-focused strategy and medical journal training create differentiation, but the small market cap of $37 million suggests resources for marketing and scaling against established competitors.

The no-subscription model diverges from industry trends toward recurring revenue streams. This could attract price-sensitive consumers but may impact long-term monetization potential, especially considering ongoing AI operational costs. The exclusive direct-to-consumer sales channel through their website limits distribution reach compared to competitors' retail presence.

The medical journal-trained AI approach is technically sophisticated and addresses a important gap in consumer health information quality. Training on 100,000+ medical journals provides a robust knowledge base for accurate health guidance. The planned integration with biometric data could enable unique insights by combining clinical knowledge with personal health metrics.

However, the beta status and initial limitation to basic Q&A functionality without sensor data integration indicates the technology is still in early stages. The real value proposition - personalized insights based on combined AI and biometric data - remains unrealized. Medical liability considerations and regulatory compliance requirements for AI-driven health advice could pose future challenges.

Newest Evie Ring feature is the first medical journal trained AI companion in a wearable

PLEASANTON, Calif., Jan. 8, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals. The new feature enables Evie users to answer health questions quickly, reliably and securely through the ring's companion app.

Planned future integration with Evie data will allow EvieAI's responses to be personalized based on users' own health metrics, including heart rate, blood oxygen, menstrual cycle information, skin temperature variability, sleep, exercise and mood captured by Evie's sensors and user logs.

Unlike general-purpose digital assistants like ChatGPT that are trained using public data, EvieAI generates clear and concise answers based on articles that have been published in over 100,000 medical journals and written by medical professionals. This helps ensure accuracy and the ability to interpret complex user queries about almost any symptom, disease, condition or procedure.

Evie's new virtual assistant also follows industry-standard encryption protocols to ensure that all user data, including sensitive health information, is protected during storage and transmission. This includes confidentiality protections ensuring that chats cannot be traced back to individual users.

"Our vision for the Evie Ring has always been to provide insights that can help users navigate their personal wellness journeys," said Tyla Bucher, Chief Marketing Officer at Movano Health. "EvieAI marks a significant leap forward in helping us fulfill that vision."

Evie is the first smart ring designed with a small gap in the ring surface and slight flex in the scratch-resistant metal to accommodate daily fluctuations in finger size due to hormonal changes and other variables, ensuring a comfortable fit at all times. It has 4+ days of battery life, recharges in just 60 minutes with the included charger, and is available exclusively through www.eviering.com in gold, rose gold and silver finishes and in sizes 5-12 with an optional complimentary sizing kit for those who don't know their ring size. It costs $269 with no subscription fees.

The beta version of EvieAI is currently available for iOS only and at no cost to existing Evie Ring customers.

About Movano Health 
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health, maker of the Evie Ring (www.eviering.com), is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health's devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and uniquely translating it into personalized and intelligent insights.

Movano Health is developing its proprietary technologies and wearable medical device solutions to enable the future use of data as a tool to proactively monitor and manage health outcomes across a number of patient populations that exist in healthcare. For more information on Movano Health, visit https://movanohealth.com/.

Forward Looking Statements
This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding plans with respect to the commercial launches of the Evie Ring and EvieMED Ring; our expectations regarding potential commercial opportunities; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development and features, product releases, clinical trials and regulatory initiatives; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors."  Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-health-launches-evieai-virtual-wellness-assistant-302344841.html

SOURCE Movano

FAQ

What is the price of Movano Health's (MOVE) Evie Ring and are there subscription fees?

The Evie Ring costs $269 with no subscription fees, including access to the new EvieAI feature for existing customers.

How is EvieAI different from other AI assistants like ChatGPT?

EvieAI is trained exclusively on over 100,000 medical journals, unlike general-purpose AI assistants that use public data, ensuring medical accuracy and expertise.

What health metrics does the Evie Ring track?

The Evie Ring tracks heart rate, blood oxygen, menstrual cycle information, skin temperature variability, sleep, exercise, and mood through its sensors and user logs.

When will EvieAI be available for Android users?

The beta version of EvieAI is currently only available for iOS users, with no announced timeline for Android availability.

How does Movano Health (MOVE) protect user data in EvieAI?

EvieAI uses industry-standard encryption protocols to protect user data during storage and transmission, ensuring chats cannot be traced back to individual users.
Movano Inc

NASDAQ:MOVE

MOVE Rankings

MOVE Latest News

MOVE Latest SEC Filings

MOVE Stock Data

7.68M
721.27k
24.94%
15.13%
13.54%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLEASANTON